Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CANB

Can B (CANB) Stock Price, News & Analysis

Can B logo

About Can B Stock (NASDAQ:CANB)

Advanced Chart

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.37
$8.24
52-Week Range
$0.27
$1.05
Volume
187,574 shs
Average Volume
189,959 shs
Market Capitalization
$2.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Can B Corp. engages in the development, production, and sale of products and delivery devices containing cannabidiol. Its product portfolio includes hemp extract oils and sprays, pain and skin care, softgels and capsules, superfoods, supplements, bath and spa, and pets. The company was founded by Rolv Eitrem Heggenhougen and Romuald Stone on October 11, 2005 and is headquartered in Hicksville, NY.

Receive CANB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Can B and its competitors with MarketBeat's FREE daily newsletter.

CANB Stock News Headlines

Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …
See More Headlines

CANB Stock Analysis - Frequently Asked Questions

Can B (CANB) raised $10 million in an initial public offering (IPO) on Tuesday, August 9th 2022. The company issued 2,000,000 shares at a price of $5.05 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Can B investors own include Fulcrum Therapeutics (FULC), Actinium Pharmaceuticals (ATNM), Provention Bio (PRVB), VIVUS (VVUS), Chimerix (CMRX), OpGen (OPGN) and Processa Pharmaceuticals (PCSA).

Company Calendar

Today
5/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:CANB
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,740,000.00
Net Margins
-1,238.33%
Pretax Margin
-1,351.68%

Debt

Sales & Book Value

Annual Sales
$2.16 million
Price / Cash Flow
N/A
Book Value
($0.28) per share
Price / Book
-0.11

Miscellaneous

Free Float
74,137,000
Market Cap
$2.56 million
Optionable
Not Optionable
Beta
1.46
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:CANB) was last updated on 5/16/2025 by MarketBeat.com Staff
From Our Partners